galectin 9, CAS No.rp174096

Features and benefits
    Item Number
    rp174096
    Grouped product items
    SKUSizeAvailabilityPrice Qty
    rp174096-500μg
    500μg
    Available within 8-12 weeks(?)
    Production requires sourcing of materials. We appreciate your patience and understanding.
    $1,334.90
    rp174096-1mg
    1mg
    Available within 8-12 weeks(?)
    Production requires sourcing of materials. We appreciate your patience and understanding.
    $2,334.90

    Basic Description

    Product Namegalectin 9, CAS No.rp174096
    SynonymsEcalectin;Gal-9;Tumor antigen HOM-HD-21
    GradeMoligand™

    Product Specifications

    CASrp174096

    Certificates

    Certificate of Analysis(COA)

    Enter Lot Number to search for COA:

    Genetic information

    Alternate NamesEcalectin;Gal-9;Tumor antigen HOM-HD-21
    Reference
    • 1. Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration., The Journal of biological chemistry, Steegborn, C C and 7 more authors.
    • 2. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences., Proceedings of the National Academy of Sciences of the United States of America, Strausberg, Robert L RL and 83 more authors.
    • 3. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)., Human genetics, Wang, Jian J and Hegele, Robert A RA.
    • 4. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase., Biochemical and biophysical research communications, Lu, Y Y, O'Dowd, B F BF, Orrego, H H and Israel, Y Y.
    • 5. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration., Clinical genetics, Wang, J J, Huff, A M AM, Spence, J D JD and Hegele, R A RA.
    • 6. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1., The Journal of biological chemistry, Yang, Guangdong G, Cao, Kun K, Wu, Lingyun L and Wang, Rui R.
    • 7. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)., Genome research, Gerhard, Daniela S DS and 115 more authors.
    • 8. Towards a proteome-scale map of the human protein-protein interaction network., Nature, Rual, Jean-François JF and 37 more authors.
    • 9. The DNA sequence and biological annotation of human chromosome 1., Nature, Gregory, S G SG and 178 more authors.
    • 10. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer., International journal of cancer, Moore, Lee E LE and 14 more authors. more

    Related Documents

    References

    1. Hirashima M.  (1999)  Ecalectin as a T cell-derived eosinophil chemoattractant..  Int Arch Allergy Immunol,  120 Suppl 1  (3): (7-10).  [PMID:10529594]
    2. Hirashima M.  (2000)  Ecalectin/galectin-9, a novel eosinophil chemoattractant: its function and production..  Int Arch Allergy Immunol,  122 Suppl 1  (3): (6-9).  [PMID:10867499]
    3. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA et al..  (2002)  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease..  Nature,  415  (6871): (536-41).  [PMID:11823861]
    4. Dunphy JL, Barcham GJ, Bischof RJ, Young AR, Nash A, Meeusen EN.  (2002)  Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge..  J Biol Chem,  277  (17): (14916-24).  [PMID:11839756]
    5. Hirashima M, Kashio Y, Nishi N, Yamauchi A, Imaizumi TA, Kageshita T, Saita N, Nakamura T.  (2004)  Galectin-9 in physiological and pathological conditions..  Glycoconj J,  19  (7-9): (593-600).  [PMID:14758084]
    6. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK.  (2005)  The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity..  Nat Immunol,  (12): (1245-52).  [PMID:16286920]
    7. Heusschen R, Freitag N, Tirado-González I, Barrientos G, Moschansky P, Muñoz-Fernández R, Leno-Durán E, Klapp BF, Thijssen VL, Blois SM.  (2013)  Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy..  Biol Reprod,  88  (1): (22).  [PMID:23242525]
    8. Heusschen R, Schulkens IA, van Beijnum J, Griffioen AW, Thijssen VL.  (2014)  Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis..  Biochim Biophys Acta,  1842  (2): (284-92).  [PMID:24333696]
    9. Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, Stevens RL, Hirashima M.  (1998)  Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes..  J Biol Chem,  273  (27): (16976-84).  [PMID:9642261]

    Solution Calculators